Gould Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.48M | Sell |
13,327
-244
| -2% | -$27.1K | 0.99% | 32 |
|
2025
Q1 | $1.52M | Sell |
13,571
-2,126
| -14% | -$238K | 1.06% | 29 |
|
2024
Q4 | $1.45M | Sell |
15,697
-431
| -3% | -$39.8K | 1.01% | 32 |
|
2024
Q3 | $1.35M | Buy |
16,128
+2,927
| +22% | +$245K | 0.89% | 33 |
|
2024
Q2 | $906K | Buy |
13,201
+756
| +6% | +$51.9K | 0.64% | 42 |
|
2024
Q1 | $912K | Buy |
12,445
+1,802
| +17% | +$132K | 0.64% | 43 |
|
2023
Q4 | $862K | Sell |
10,643
-1,035
| -9% | -$83.8K | 0.63% | 41 |
|
2023
Q3 | $865K | Buy |
11,678
+817
| +8% | +$60.5K | 0.7% | 40 |
|
2023
Q2 | $837K | Buy |
10,861
+10,710
| +7,093% | +$825K | 0.64% | 41 |
|
2023
Q1 | $12.6K | Buy |
151
+51
| +51% | +$4.24K | 0.01% | 140 |
|
2022
Q4 | $8.59K | Sell |
100
-25
| -20% | -$2.15K | 0.01% | 152 |
|
2022
Q3 | $8K | Buy |
+125
| New | +$8K | 0.01% | 148 |
|